Sign up to save your podcasts
Or
Share Corporate reputation in the age of GLP-1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Corporate reputation in the age of GLP-1
Listen to Thomas Fife-Schaw and Nick Gabery Adams, former VP of Corporate Brand at Novo Nordisk, discuss how GLP-1 medications like Ozempic and Wegovy are changing the pharmaceutical landscape. From reshaping corporate reputation, to boosting investor confidence, discover how these drugs are rewriting the rules for pharma brands.
View all episodes
By Ipsos UK
3.5
22 ratings
Listen to Thomas Fife-Schaw and Nick Gabery Adams, former VP of Corporate Brand at Novo Nordisk, discuss how GLP-1 medications like Ozempic and Wegovy are changing the pharmaceutical landscape. From reshaping corporate reputation, to boosting investor confidence, discover how these drugs are rewriting the rules for pharma brands.
More shows like Ipsos UK Podcast
View all
Economist Podcasts
4,177 Listeners
In Our Time
5,532 Listeners
Pivot
9,590 Listeners
The Media Show
35 Listeners
Political Fix
156 Listeners
Coffee House Shots
178 Listeners
Hard Fork
5,487 Listeners
The Rest Is Politics
3,145 Listeners
Ukraine: The Latest
1,864 Listeners
Battleground
330 Listeners
The News Agents
1,055 Listeners
The Rest Is Politics: US
2,260 Listeners
Quiet Riot
40 Listeners